CYP2C9*1B promoter polymorphisms, in linkage with CYP2C19*2, affect phenytoin autoinduction of clearance and maintenance dose by Chaudhry Amarjit S, Urban Thomas J, Lamba Jatinder K, Birnbaum Angela K, Remmel Rory P, Subramanian Murali, Strom Stephen, You Joyce H, Kasperaviciute Dalia, Catarino Claudia B, Radtke Rodney A, Sisodiya Sanjay M, Goldstein David B, Schuetz Erin G in The Journal of pharmacology and experimental therapeutics (2010).

[PMID: 19855097] PubMed


Discussed In Paper


Variant Annotations

Sign in to see variant annotations.

Dosing Information

No dosing information annotated.